Advancing the Science of Management of Arrhythmic Disease in Children and Adult Congenital Heart Disease Patients Within the Last 25 Years

Overview

Journal Europace

Publisher Oxford University Press

Specialties Cardiology & Vascular Diseases
Physiology

Date 2023 Aug 25

PMID 37622573

Authors

Thomas Paul

Ulrich Krause

Shubhayan Sanatani

Susan P Etheridge

Affiliations

Soon will be listed here.

Abstract

This review article reflects how publications in EP Europace have contributed to advancing the science of management of arrhythmic disease in children and adult patients with congenital heart disease within the last 25 years. A special focus is directed to congenital atrioventricular (AV) block, the use of pacemakers, cardiac resynchronization therapy devices, and implantable cardioverter defibrillators in the young with and without congenital heart disease, Wolff-Parkinson-White syndrome, mapping and ablation technology, and understanding of cardiac genomics to untangle arrhythmic sudden death in the young.

Citing Articles

Landiolol is effective and safe in paediatric supraventricular tachycardia: evidence from a European prospective multicentre open-label phase III study (LANDI-PED).

Michel-Behnke I, Muller M, Stiller B, Kriebel T, Kanaan M, Kornyei L Europace. 2025; 27(2).

PMID: 39947241 PMC: 11879349. DOI: 10.1093/europace/euaf025.

Ventricular septal defect characteristics influence presence of septal anatomical isthmuses in patients with repaired tetralogy of Fallot.

Wallet J, Kimura Y, Blom N, Hazekamp M, Bartelings M, Jongbloed M Europace. 2024; 26(12).

PMID: 39675919 PMC: 11646654. DOI: 10.1093/europace/euae283.

Intermittent ventricular preexcitation in children: not always a low-risk condition.

Yammine M, Tamborrino P, Flore F, Di Mambro C, Pazzano V, Di Marzio S Europace. 2024; 26(10).

PMID: 39351912 PMC: 11481285. DOI: 10.1093/europace/euae250.

2024 updated European Heart Rhythm Association core curriculum for physicians and allied professionals: a statement of the European Heart Rhythm Association of the European Society of Cardiology.

Trines S, Moore P, Burri H, Goncalves Nunes S, Massoullie G, Merino J Europace. 2024; 26(11).

PMID: 39298665 PMC: 11528301. DOI: 10.1093/europace/euae243.

A computational study on the influence of antegrade accessory pathway location on the 12-lead electrocardiogram in Wolff-Parkinson-White syndrome.

Gillette K, Winkler B, Kurath-Koller S, Scherr D, Vigmond E, Bar M Europace. 2024; 27(2).

PMID: 39259657 PMC: 11879338. DOI: 10.1093/europace/euae223.

References

Chubb H, Campbell R, Motonaga K, Ceresnak S, Dubin A . Management of Asymptomatic Wolff-Parkinson-White Pattern by Pediatric Electrophysiologists. J Pediatr. 2019; 213:88-95.e1. DOI: 10.1016/j.jpeds.2019.05.058. View

OConnor M, Riad O, Shi R, Hunnybun D, Li W, Jarman J . Left bundle branch area pacing in congenital heart disease. Europace. 2022; 25(2):561-570. PMC: 9935007. DOI: 10.1093/europace/euac175. View

Yoshida S, Suzuki T, Yoshida Y, Watanabe S, Nakamura K, Sasaki T . Feasibility and safety of transseptal puncture procedures for radiofrequency catheter ablation in small children weighing below 30 kg: single-centre experience. Europace. 2015; 18(10):1581-1586. DOI: 10.1093/europace/euv383. View

Drago F, Righi D, Placidi S, Russo M, Di Mambro C, Silvetti M . Cryoablation of right-sided accessory pathways in children: report of efficacy and safety after 10-year experience and follow-up. Europace. 2013; 15(11):1651-6. DOI: 10.1093/europace/eut122. View

Koyak Z, de Groot J, Bouma B, Zwinderman A, Silversides C, Oechslin E . Sudden cardiac death in adult congenital heart disease: can the unpredictable be foreseen?. Europace. 2016; 19(3):401-406. DOI: 10.1093/europace/euw060. View

Luderitz B . WPW syndrome: the 'Rosetta stone' of rhythmology. The history of the Rosetta stone. Europace. 2009; 11(3):285-8. DOI: 10.1093/europace/eun353. View

Ksiazczyk T, Jaron A, Pietrzak R, Werner B . Assessment of the physical performance in children with asymptomatic pre-excitation. Europace. 2021; 24(5):855-859. DOI: 10.1093/europace/euab171. View

Labombarda F, Hamilton R, Shohoudi A, Aboulhosn J, Broberg C, Chaix M . Increasing Prevalence of Atrial Fibrillation and Permanent Atrial Arrhythmias in Congenital Heart Disease. J Am Coll Cardiol. 2017; 70(7):857-865. DOI: 10.1016/j.jacc.2017.06.034. View

Etheridge S, Escudero C, Blaufox A, Law I, Dechert-Crooks B, Stephenson E . Life-Threatening Event Risk in Children With Wolff-Parkinson-White Syndrome: A Multicenter International Study. JACC Clin Electrophysiol. 2018; 4(4):433-444. DOI: 10.1016/j.jacep.2017.10.009. View

10.

Buber J, Ackley T, Daniels C, Roble S, Mah M, Kamp A . Outcomes following the implantation of cardioverter-defibrillator for primary prevention in transposition of the great arteries after intra-atrial baffle repair: a single-centre experience. Europace. 2015; 18(7):1016-22. DOI: 10.1093/europace/euv297. View

11.

Klehs S, Paech C, Bertagnolli L, Markel F, Dahnert I, Gebauer R . Coherent mapping of atrial tachycardias in patients with congenital heart disease. Europace. 2023; 25(4):1475-1481. PMC: 10105870. DOI: 10.1093/europace/euad024. View

12.

Fender E, Killu A, Cannon B, Friedman P, McLeod C, Hodge D . Lead extraction outcomes in patients with congenital heart disease. Europace. 2016; 19(3):441-446. DOI: 10.1093/europace/euw049. View

13.

Khairy P, Van Hare G, Balaji S, Berul C, Cecchin F, Cohen M . PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society.... Heart Rhythm. 2014; 11(10):e102-65. DOI: 10.1016/j.hrthm.2014.05.009. View

14.

Lewandowski M, Sterlinski M, Maciag A, Syska P, Kowalik I, Szwed H . Long-term follow-up of children and young adults treated with implantable cardioverter-defibrillator: the authors' own experience with optimal implantable cardioverter-defibrillator programming. Europace. 2010; 12(9):1245-50. DOI: 10.1093/europace/euq263. View

15.

Plymen C, Finlay M, Tsang V, OLeary J, Picaut N, Cullen S . Haemodynamic consequences of targeted single- and dual-site right ventricular pacing in adults with congenital heart disease undergoing surgical pulmonary valve replacement. Europace. 2014; 17(2):274-80. PMC: 4309992. DOI: 10.1093/europace/euu281. View

16.

Nielsen J, Kottkamp H, Piorkowski C, Gerds-Li J, Tanner H, Hindricks G . Radiofrequency ablation in children and adolescents: results in 154 consecutive patients. Europace. 2006; 8(5):323-9. DOI: 10.1093/europace/eul021. View

17.

Zeb M, Curzen N, Veldtman G, Yue A, Roberts P, Wilson D . Potential eligibility of congenital heart disease patients for subcutaneous implantable cardioverter-defibrillator based on surface electrocardiogram mapping. Europace. 2015; 17(7):1059-67. DOI: 10.1093/europace/euu375. View

18.

de Groot N, Lukac P, Schalij M, Makowski K, Szili-Torok T, Jordaens L . Long-term outcome of ablative therapy of post-operative atrial tachyarrhythmias in patients with tetralogy of Fallot: a European multi-centre study. Europace. 2011; 14(4):522-7. DOI: 10.1093/europace/eur313. View

19.

Jacquemart E, Combes N, Duthoit G, Bessiere F, Ladouceur M, Iserin L . Cardiac resynchronization therapy in patients with congenital heart disease and systemic right ventricle. Heart Rhythm. 2021; 19(4):658-666. DOI: 10.1016/j.hrthm.2021.11.032. View

20.

Hassan A, Tan N, Aung H, Connolly H, Hodge D, Vargas E . Outcomes of atrial arrhythmia radiofrequency catheter ablation in patients with Ebstein's anomaly. Europace. 2017; 20(3):535-540. DOI: 10.1093/europace/euw396. View